Assessment of Definitive Residual Pituitary-Adrenal Function and of Hydrocortisone Replacement Therapy 10 to 14 Days after Microsurgery for Pituitary Adenomas

H. Stracke; O. Schröder; H. Bleyl; H. Schatz

doi:10.1055/s-2007-1014729

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 1984; 16(3): 157-158
DOI: 10.1055/s-2007-1014729

Short Communications

Assessment of Definitive Residual Pituitary-Adrenal Function and of Hydrocortisone Replacement Therapy 10 to 14 Days after Microsurgery for Pituitary Adenomas

H. Stracke, O. Schröder, H. Bleyl¹ , H. Schatz

III. Medizinische Klinik und Poliklinik, Gießen, Germany
¹Institut für Klinische Chemie und Pathobiochemie der Universität Gießen, Gießen, Germany

Abstract

als PDF herunterladen

Summary

Anterior pituitary function was evaluated by a combined stimulation test 10-14 days and again 6-8 months after micro-surgery for pituitary tumors. It was found that definite residual pituitary-adrenal function could accurately be assessed already 10-14 days after operation, as judged by the subsequent testing. By this means, hydrocortisone replacement therapy necessary one year after operation could be predicted.

PDF (147 kb)

>